TheraVet announced the signing of an exclusive distribution agreement with Vetpharma. This agreement represents a significant step forward for the distribution of BIOCERA-VET® product range, which is now available in the five continents. Altogether this agreement covers 24 countries representing over 150 million of dogs and where the awareness of animal healthcare needs is currently increasing, particularly in major countries like the Scandinavians, Australia, Japan, South Africa and Brazil where a CAGR of 13.1% is forecasted from 2022 to 2027 for the animal healthcare market.